Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria-Reference-Cited by-同舟云学术

Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria

Published:2017-01-31 Issue:5 Volume:72 Page:1421-1428
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Tam Vincent H.,Chang Kai-Tai,Zhou Jian,Ledesma Kimberly R.,Phe Kady,Gao Song,Van Bambeke Françoise,Sánchez-Díaz Ana María,Zamorano Laura,Oliver Antonio,Cantón Rafael

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/5/1421/13703548/dkx001.pdf

Reference36 articles.

1. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections;Diagn Microbiol Infect Dis,2011

2. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia;Diagn Microbiol Infect Dis,2009

3. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia;Diagn Microbiol Infect Dis,2007

4. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem;Pharmacotherapy,2004

5. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion;Int J Antimicrob Agents,2009

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-12

2. Oral antimicrobial agents in patients with short bowel syndrome: the importance of considering TDM;Journal of Antimicrobial Chemotherapy;2024-09-13

3. Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review;Frontiers in Antibiotics;2024-06-17

4. Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis;Critical Care;2024-04-16

5. Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP;Antibiotics;2024-03-25